September 2020
S M T W T F S
 12345
6789101112
13141516171819
20212223242526
27282930  

News Categories

Site search

More About The Peru Gazette

The editor is John Ryan at email: perugazette@gmail.com. The Peru Gazette is a free community, education and information website. It is non-commercial and does not accept paid advertising.

Comment Policy

The Peru Gazette welcomes comments on posted stories. The author MUST include his/her first and last name. No  foul or libelous language permitted. The Peru Gazette reserves the right to not publish a comment.

Recent Comments

TOPS RAISES OVER $333,000 DURING 50TH ANNIVERSARY YEAR FOR JDRF ANNUAL CAMPAIGN

Tops Friendly Markets, a leading full-service grocery retailer in New York, northern Pennsylvania, and Vermont, is pleased to announce that is has raised over $333,000 for JDRF (formerly known as the Juvenile Diabetes Research Foundation) during its annual campaign.  This year marks the 50th year JDRF is embarking on a campaign to find a cure for type 1 diabetes (T1D).

Now more than ever the onset of T1D can happen suddenly, impacting people of any age, affecting them every moment of every day, and it lasts a lifetime.  That’s why Tops was proud to join them in the fight as it launched its 27th annual JDRF Campaign.  Since 1993 Tops has raised more than $13 million dollars for the cause with Tops fund-raising efforts putting the company in the top 10 fund-raisers in the country for many years.

This year Tops Annual JDRF Sneaker Campaign began Sunday, August 2 and ran through Saturday, August 22, 2020.  The goal was to raise money to help fund research to help find a cure for T1D.  The paper sneaker, which was designed by a Tops associate back in 1993 and is now widely used nationally as well as internally in JDRF fundraising campaigns, was sold at Tops registers for a $1.00 donation.

Based on the latest reporting from the CDC, approximately 1.6 million people are affected by T1D in the United States.  That is an increase of 30% in just two years, with medical expenses for those with T1D being three times higher than for people without diabetes.